Floatz logo

236 assets in Ovarian Carcinoma

Therapeutic assets addressing Ovarian Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
pf-07826390
Ovarian Carcinoma
PfizerP1CC (41)
Vistusertib
Ovarian Carcinoma
M.D. Anderson Cancer CenterP1CC (41)
1-118-Signal regulatory protein ? (human) fusion protein with immunoglobulin G4 [128-proline] (human ?4-chain C region C-terminal fragment), dimer
Ovarian Carcinoma
PfizerP1/2CC (40)
27T51
Ovarian Carcinoma
Regeneron PharmaceuticalsP1C (39)
Alectinib
Ovarian Carcinoma
OHSU Knight Cancer InstituteEarly P1C (39)
Amg 794
Ovarian Carcinoma
AmgenP1C (39)
Biological Ni-1801
Ovarian Carcinoma
Light Chain Bioscience - Novimmune SAP1C (39)
Car.B7-H3
Ovarian Carcinoma
UNC Lineberger Comprehensive Cancer CenterP1C (39)
CRX100
Ovarian Carcinoma
BioEclipse TherapeuticsP1C (39)
ct-95
Ovarian Carcinoma
Context Therapeutics Inc.P1C (39)
Entrectinib
Ovarian Carcinoma
OHSU Knight Cancer InstituteEarly P1C (39)
Fapi-46
Ovarian Carcinoma
Karolinska University HospitalP1C (39)
Hyaluronidase Zzxf
Ovarian Carcinoma
OHSU Knight Cancer InstituteEarly P1C (39)
ic9-car.b7-h3 t cells
Ovarian Carcinoma
UNC Lineberger Comprehensive Cancer CenterP1C (39)
Imiquimod
Ovarian Carcinoma
Toray Industries, IncP1C (39)
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor Receptor Type Vegfr-2 Extracellular Domain) (Human Monoclonal Imc-1121B .Gamma.-Chain), Disulphide With Human Monoclonal Imc-1121B .Kappa.-Chain, Dimer
Ovarian Carcinoma
Toray Industries, IncP1C (39)
Immunoglobulin G1 [De-C-Terminal-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mus Musculus Clone Bca101 ?1-Chain), Disulfide With Human-Mus Musculus Clone Bca101 ?-Chain Fusion Protein With Peptide Linker (Ggggs)3 Fusion Protein With 23-159-Transforming Growth Factor ? Receptor Tgfbr2 (Human), Dimer
Ovarian Carcinoma
Bicara TherapeuticsP1C (39)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer
Ovarian Carcinoma
Regeneron PharmaceuticalsP1C (39)
Itil-306
Ovarian Carcinoma
Instil BioP1C (39)
MDG1015
Ovarian Carcinoma
Medigene AGP1C (39)
Monoclonal Antibody Trk-950
Ovarian Carcinoma
Toray Industries, IncP1C (39)
sz011 car-nk
Ovarian Carcinoma
Shantou University Medical CollegeEarly P1C (39)
TH19P01-DOCETAXEL
Ovarian Carcinoma
TheratechnologiesP1C (39)
Vemurafenib
Ovarian Carcinoma
OHSU Knight Cancer InstituteEarly P1C (39)
Recombinant L-Ifn Adenovirus
Ovarian Carcinoma
Shanghai Fengxian District Central HospitalEarly P1C (38)
Alpha-Type-1 Polarized Dendritic Cells
Ovarian Carcinoma
Roswell Park Cancer InstituteP1/2C (34)
Vobramitamab Duocarmazine
Ovarian Carcinoma
MacroGenicsP1D (31)
Etodolac
Ovarian Carcinoma
Memorial Sloan Kettering Cancer CenterN/AD (30)
Indocyanine Green
Ovarian Carcinoma
Başakşehir Çam & Sakura City HospitalN/AD (30)
Luveltamab Tazevibulin
Ovarian Carcinoma
Sutro Biopharma, Inc.P2/3D (30)
Sasanlimab
Ovarian Carcinoma
PfizerP1D (28)
Tart Cherry
Ovarian Carcinoma
University of California, DavisP2NR ()
tng348
Ovarian Carcinoma
Tango Therapeutics, Inc.P1/2NR ()
Tumor Neoantigen-Sensitized Autologous Dendritic Cell
Ovarian Carcinoma
Peking University Third HospitalN/ANR ()
Showing 201 to 236 of 236 assets
PreviousPage 5 of 5Next